Literature DB >> 25623637

On the search for novel treatment modalities for HIV-associated intestinal barrier dysfunction.

Stelios F Assimakopoulos1, Dimitra Dimitropoulou2, Markos Marangos2, Charalambos A Gogos2.   

Abstract

Mesh：

Year:  2015        PMID： 25623637     DOI： 10.1007/s15010-015-0728-3

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  3 in total

1.  Serum-derived bovine immunoglobulin/protein isolate should be considered in patients with HIV gut barrier dysfunction.

Authors:  M S Gelfand; B P Burnett
Journal:  Infection       Date:  2015-01-30       Impact factor: 3.553

Review 2.  Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies.

Authors:  S F Assimakopoulos; D Dimitropoulou; M Marangos; C A Gogos
Journal:  Infection       Date:  2014-07-29       Impact factor: 3.553

3.  Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy.

Authors:  David M Asmuth; Zhong-Min Ma; Anthony Albanese; Netanya G Sandler; Sridevi Devaraj; Thomas H Knight; Neil M Flynn; Tammy Yotter; Juan-Carlos Garcia; Emily Tsuchida; Tsung-Teh Wu; Daniel C Douek; Christopher J Miller
Journal:  AIDS       Date:  2013-09-10       Impact factor: 4.177
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.